%0 Journal Article
%T 5‐Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
%J Journal of sexual medicine
%D 2008
%A Erdemir, Fikret
%A Harbin, Andrew
%A Hellstrom, Wayne JG
%V 5
%N 12
%P 2917-2924
%X Introduction.  Benign prostatic hyperplasia (BPH) is a common problem affecting middle-aged and elderly men. First-line medical therapy includes α 1blockers and 5α-reductase inhibitors (5ARIs), such as finasteride and dutasteride. 5ARI use has been associated with adverse sexual outcomes, including erectile dysfunction (ED), ejaculatory dysfunction (EjD), and decreased libido.<p />
%G 
%I John Wiley and Sons
%@ 1743-6095
%U http://dx.doi.org/10.1111/j.1743-6109.2008.01001.x